Related Experiment Video
Updated: Jul 2, 2026
Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
Using an intrauterine device in immunocompromised women
Hyacinth Browne1, Somjate Manipalviratn, Alicia Armstrong
1Program in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA. brownehy@mail.nih.gov
Intrauterine devices (IUDs) offer safe contraception and menses suppression for immunocompromised women. Current data indicate no increased risk of pelvic infections in this population when using IUDs.
Area of Science:
- Reproductive Health
- Infectious Disease
Background:
- Intrauterine devices (IUDs) are effective contraceptives.
- Immunocompromised women require safe and reliable contraception or menses suppression options.
- Estrogen-containing contraceptives may be contraindicated in some women.
Purpose of the Study:
- To review the literature on the safety and efficacy of IUDs in immunocompromised women.
- To assess the risk of pelvic infections associated with IUD use in this specific population.
Main Methods:
- Literature review of existing studies on IUD use in immunocompromised women.
- Analysis of data regarding pelvic infection rates in this cohort.
Main Results:
- A sparse but available body of literature exists on IUD use in immunocompromised women.
- Current data do not suggest an elevated risk of pelvic infections for immunocompromised women using IUDs.
Conclusions:
- Intrauterine devices (IUDs) are a viable option for contraception and menses suppression in immunocompromised women.
- IUDs may serve as an alternative for women with contraindications to estrogen therapy.
- The risk of pelvic infection does not appear to be significantly higher in immunocompromised women using IUDs.
More Related Videos
03:40Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
08:29Measurement of Four Uterine NK Cell Subtypes Using Multiplexed Fluorescent Immunohistochemical Staining in Women with Repeated Implantation Failure
Published on: October 25, 2024
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
01:24In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...